CBS 2019
CBSMD教育中心
中 文

肺动脉高压

Abstract

Recommended Article

Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility Study Medical Therapy for CTEPH: Is There Still Space for More? Risk Stratification in PAH Definition and Management of Segmental Pulmonary Hypertension Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature Pulmonary Artery Denervation: An Alternative Therapy for Pulmonary Hypertension

Original Research2013 Sep 17;62(12):1092-1100.

JOURNAL:J Am Coll Cardiol. Article Link

Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension)

Chen SL, Zhang FF, Xu J et al. Keywords: 6-min walk test; 6MWT; CO; IPAH; MPA; N-terminal brain natriuretic peptide; NT-BNP; PA; PADN; PAH; PAOP; PAP; PVR; RA; RV; TPG; Tei; cardiac output; denervation; idiopathic pulmonary arterial hypertension; main pulmonary artery; pulmonary artery; pulmonary artery denervation; pulmonary artery hypertension; pulmonary artery occlusive pressure; pulmonary artery pressure; pulmonary vascular resistance; right atrium/atrial; right ventricle/ventricular; transpulmonary pressure gradient; tricuspid excursion index

Full Text PDF